http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100224370-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06c7c12d15f5c19c7408f6a3e93bfb58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6c19b1a16c61b7d0f279aedce237f50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 1996-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bb0fbd7b11d045aad4cb4508e8c1b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59b209a83dc05f6d96a459a62ed30f7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda11bdb8620ea5d1d86205c51334f04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc32ee0c3db1dc36b9f54663b24fa10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b2b620b93b473b0384f88af03a87165 |
| publicationDate | 1999-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100224370-B1 |
| titleOfInvention | Nifecotinyl-2-pyrrolidinone, preparation method thereof and anticonvulsant using the same |
| abstract | The present invention relates to nifecotyl-2-pyrrolidinone represented by the following general formula (1), a pharmaceutically acceptable salt thereof, and an anticonvulsant having the same as an active ingredient.n n n n n n n n The substance according to the present invention is transformed into an amide by combining γ-aminobutyl acid (GABA), an amino acid-based compound, and nipecotic acid, which is one of the γ-aminobutyl acid intake inhibitors, Increases fat solubility than the original substance, facilitating the passage of BBB, and after being absorbed, it is degraded by in vivo yeast and acts as a γ-aminobutyl acid (GABA) and γ-aminobutyl acid intake inhibitor. Possible, ie two active substances, the application shows a very wide range of anticonvulsive activity. |
| priorityDate | 1996-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.